Science-Driven Innovations

Enabling precision medicine today, accelerating personalized therapies for tomorrow.
Pharmacogenomics and Precision Medicine

Science-Driven Innovations

Enabling precision medicine today, accelerating personalized therapies for tomorrow.

Complete pharmacogenomics testing portfolio

As the leader in pharmacogenomics (PGx), RPRD offers a complete portfolio of leading-edge testing and supporting services. Whether you are looking for a Whole Pharmacogenomics Scan that analyzes nearly all the actionable PGx genetic variants, a customized PGx panel, a targeted panel (CEP72, NUDT15 and TPMT) that guides patient-specific treatment modalities, or a sequencing service on various next-generation sequencing (NGS) platforms, we are the right partner for you.

Pharmacogenomics Testing in CLIA Laboratory
Insights
Why implement pharmacogenomics?

In the US, 100,000 deaths occur annually due to adverse drug reactions (ADRs), and 1 out of 5 injuries or deaths occur because of ADRs in hospitalized patients. Implementing pharmacogenomics (PGx) could potentially reduce ADRs-related injuries and deaths.

Webinar

Dr. Shannon Manzi serves as the Director of the Clinical pharmacogenomics (PGx) Service, and is instrumental in developing a team-based precision medicine program at Boston Children’s Hospital. Dr. Manzi, together with Dr. Scharer, Chief Medical Officer at RPRD, share their hands-on experience in PGx implementation and showcase how the clinical PGx service improves patient outcome and reduces the overall cost of care.

 

Important pharmacogenetics genes

Learn more about the important pharmacogenetics (PGx) genes. The detail includes how the gene impacts the drug response and a brief summary of the clinical recommendations provided by Clinical Pharmacogenetics Implementation Consortium (CPIC).

News & Updates

RPRD is proud to be one of the clinical laboratories performing CYP2D6 testing for the Genetic Testing Reference Materials Coordination Program (GeT-RM). We not only confirmed the genetic information of the existing samples, but also successfully interrogated samples with rare, or complex diplotypes. We are honored to contribute to the important PGx quality-assurance and quality-control efforts.

EMPOWER PERSONALIZED CARE

End-to-end solutions to enable precision medicine

We leverage advanced technologies and our decades-long experience in genetics research to bring pharmacogenetics into the mainstream. We empower clinicians with complete solutions, so they can focus on providing better care for their patients.

Evidence-based high-quality solutions

Our PGx solutions are formulated based on the latest clinical practice guidelines, which are supported by rigorous peer-reviewed clinical and scientific evidence.

Genetics in Drug Responses

ACCELERATE PERSONALIZED THERAPIES

Our drug development partners trust our academic excellence and decades of scientific research experience in genetics and the impact of genetics on drug responses. Through our continued research in modern technologies and drug R&D, we help our partners pursue personalized therapies to achieve better care for tomorrow.

PGx TestimonialMy team and I are very proud of the tests we offer because they are developed using strong peer-reviewed scientific evidence and the industry’s highest standards. The tests are highly accurate, actionable and ethnicity-unbiased, as they investigate both common and rare variants, and our diagnostic interpretation adheres to the latest clinical guidelines. Our goal is to ensure that patients receive the most up-to-date, comprehensive and accurate results possible.

- Amy Turner, Director of Research and Development

Unlock the power of science

RPRD is accelerating personalized therapies of tomorrow through its long-term commitment to advancing PGx with scientific breakthroughs and innovations.

PGx Diagnostic Solutions

RPRD’s experience in precision medicine and its CLIA-certified laboratory offer a wide range of PGx diagnostic services to meet your unique needs.